Home - Products - GPCR/G Protein - Antibacterial - Ciprofloxacin hydrochloride hydrate

Ciprofloxacin hydrochloride hydrate

CAS No. 86393-32-0

Ciprofloxacin hydrochloride hydrate( Bay-09867 hydrochloride monohydrate | Ciloxan | Ceprimax | Oftacilox )

Catalog No. M21202 CAS No. 86393-32-0

Ciprofloxacin hydrochloride hydrate is a fluoroquinolone antibioticis an antibiotic used to treat a number of bacterial infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ciprofloxacin hydrochloride hydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Ciprofloxacin hydrochloride hydrate is a fluoroquinolone antibioticis an antibiotic used to treat a number of bacterial infections.
  • Description
    Ciprofloxacin hydrochloride hydrate is a fluoroquinolone antibioticis an antibiotic used to treat a number of bacterial infections.(In Vitro):Ciprofloxacin (Bay-09867) hydrochloride monohydrate (5-50 μg/mL; 0-24 h; tendon cells) inhibits cell proliferation and causes cell cycle arrest at the G2/M phase.Ciprofloxacin (Bay-09867) hydrochloride monohydrate shows potent activity against Y. pestis and B. anthracis with MIC90 of 0.03 μg/mL and 0.12 μg/mL, respectively.(In Vivo):Ciprofloxacin (Bay-09867) hydrochloride monohydrate (30 mg/kg; i.p.; for 24 hours; BALB/c mice) has protection against Y. pestis in murine model of pneumonic plague.Ciprofloxacin (Bay-09867) hydrochloridemonohydrate (100 mg/kg; i.g.; daily, for 4 weeks; C57BL/6J mice) accelerates aortic root enlargement and increases the incidence of aortic dissection and rupture by decreases LOX level and increases MMP levels and activity in the aortic wall.Ciprofloxacin (Bay-09867) hydrochloride monohydrate (100 mg/kg; i.g.; daily, for 4 weeks; C57BL/6J mice) induces DNA damage and release of DNA to the cytosol, mitochondrial dysfunction, and activation of cytosolic DNA sensor signaling. Ciprofloxacin lactate increases apoptosis and necroptosis in the aortic wall.
  • In Vitro
    Ciprofloxacin (Bay-09867) hydrochloride monohydrate (5-50 μg/mL; 0-24 h; tendon cells) inhibits cell proliferation and causes cell cycle arrest at the G2/M phase.Ciprofloxacin (Bay-09867) hydrochloride monohydrate shows potent activity against Y. pestis and B. anthracis with MIC90 of 0.03 μg/mL and 0.12 μg/mL, respectively.Cell Viability Assay Cell Line:Tendon cells Concentration:5, 10, 20 and 50 μg/mL Incubation Time:24 hours Result:Decreased the cellularity of tendon cells.Cell Cycle Analysis Cell Line:Tendon cellsConcentration:50 μg/mL Incubation Time:24 hours Result:Arrested cell cycle at the G2/M phase and inhibited cell division in tendon cells.Western Blot Analysis Cell Line:Tendon cells Concentration:50 μg/mL Incubation Time:0, 6, 12, 17 and 24 hours Result:Down-regulated the expression of CDK-1 and cyclin B protein and mRNA. Up-regulatedthe expression of PLK-1 protein.
  • In Vivo
    Ciprofloxacin (Bay-09867) hydrochloride monohydrate (30 mg/kg; i.p.; for 24 hours; BALB/c mice) has protection against Y. pestis in murine model of pneumonic plague.Ciprofloxacin (Bay-09867) hydrochloride monohydrate (100 mg/kg; i.g.; daily, for 4 weeks; C57BL/6J mice) accelerates aortic root enlargement and increases the incidence of aortic dissection and rupture by decreases LOX level and increases MMP levels and activity in the aortic wall.Ciprofloxacin (Bay-09867) hydrochloride monohydrate (100 mg/kg; i.g.; daily, for 4 weeks; C57BL/6J mice) induces DNA damage and release of DNA to the cytosol, mitochondrial dysfunction, and activation of cytosolic DNA sensor signaling. Ciprofloxacin lactate increases apoptosis and necroptosis in the aortic wall. Animal Model:BALB/c mice Dosage:30 mg/kg Administration:Intraperitoneal injection; for 24 hours Result:Reduced the lung bacterial load in murine model of pneumonic plague.Animal Model:C57BL/6J mice Dosage:100 mg/kg Administration:Oral gavage; daily, for 4 weeks Result:Had aortic destruction that was accompanied by decreased LOX expression and increased MMP expression and activity.Animal Model:C57BL/6J mice Dosage:100 mg/kg Administration:Oral gavage; daily, for 4 weeks Result:Caused mitochondrial DNA and nuclear DNA damage, leading to mitochondrial dysfunction and ROS production. Increased apoptosis and necroptosis in the aortic wall.
  • Synonyms
    Bay-09867 hydrochloride monohydrate | Ciloxan | Ceprimax | Oftacilox
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Bacterial
  • Research Area
    Inflammation/Immunology
  • Indication
    Infections of the genitourinary system respiratory tract gastrointestinal tract

Chemical Information

  • CAS Number
    86393-32-0
  • Formula Weight
    385.8
  • Molecular Formula
    C17H21ClFN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:8 mg/mL (20.74 mM)H2O:10 mg/mL (25.92 mM)
  • SMILES
    Cl.O.O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O
  • Chemical Name
    1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid hydrate hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hamblin K A Armstrong S J Barnes K B et al. Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague[J]. Frontiers in Microbiology 2017 8.
molnova catalog
related products
  • Morinidazole

    Morinidazole shows antibacterial activity and can be used in studies about bacterial infections research such as appendicitis and pelvic inflammatory disease caused by anaerobic bacteria.

  • Ceftibuten dihydrate

    Ceftibuten dihydrate is the dihydrate form of ceftibuten, and is a third-generation cephalosporin with antibacterial activity.

  • LYS228

    LYS228 is a novel potent monobactam that shows potent activity against carbapenem-resistant isolates of Enterobacteriaceae with MIC90 of 2 ug/ml.